Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hair transplants can help transgender individuals match their appearance with their gender identity.

PCOS causes hormonal imbalances, irregular periods, and can lead to infertility, obesity, and mental health issues.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

Transgender patients face unique skin issues due to hormone treatments and surgeries.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Gender identity can be more diverse than just male or female.

New hair transplant method allows for hair regrowth in the donor area and less scarring.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

New methods may speed up drug development for male subfertility.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Lip feminization is important for transgender women, requiring personalized approaches and expert consultation for best results.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Bicalutamide may help treat female pattern hair loss.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Laser treatment for skin conditions VEN and ILVEN is effective and liked by patients.